Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,664.00    -4.00 (-0.24%)
Bid:
1,662.00
Ask:
1,668.00
Spread: 6.00 (0.361%)
Market Cap: £490.08m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

AGM Trading Update

27 Jan 2023 07:00

RNS Number : 0331O
Avon Protection PLC
27 January 2023
 

27 January 2023

Avon Protection plc

("Avon Protection" or "the Group")

AGM Trading Update

Avon Protection is pleased to announce a trading update for the first quarter of its 2023 financial year ("Q1" or the "Period"), ahead of its Annual General Meeting today.

 

Respiratory and head protection sales were at similar levels to Q1 2022, following a strong final quarter in respiratory last year. Overall, revenue in Q1 was up 6% versus last year, driven by the previously anticipated increase in sales of armour products.

 

Work to ramp up production on the Next-Generation IHPS helmet is ongoing, ahead of first deliveries in H2. The First Article Testing process for the ACH GEN II helmet is progressing well, with initial revenue expected in the first half of 2024. Body armour pressing and assembly is progressing as planned, though costs per unit remain high. We continue to expect armour production to end in Q3, with completion of deliveries by the end of the financial year.

The Group has a strong order pipeline for our leading respiratory products and further growth in demand is expected for head protection range. Due to the normal seasonality and timing of order receipts, revenue will be weighted to the second half, with FY23 expected to represent a year of good progress for Avon Protection.

 

Bruce Thompson, Non-Executive Chair, said:

"Jos Sclater joined Avon Protection as our new Chief Executive Officer at the start of this month and we welcome him to the Group. We look forward to making further progress on our key operational and strategic initiatives as we enter a new chapter of delivery, improvement and growth under his leadership."

 

Avon Protection will report its Interim Results for the six months ending 31 March 2023 on 23 May 2023.

 

For further enquiries, please contact:

 

Avon Protection plc

Jos Sclater, Chief Executive Officer

+44 1225 896 848

Rich Cashin, Chief Financial Officer

Rory Wiltshire, Investor Relations Manager

MHP

Tim Rowntree

+44 7710 032 657

Alan Tovey

avonprotection@mhpgroup.com

Pete Lambie

 

 

Legal Entity Identifier: 213800JM1AN62REBWA71

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

About Avon Protection:

Avon Protection make products that are trusted to protect the world's militaries and first responders.

Our dedicated teams achieve this by developing mission-critical solutions that enhance our customers' performance, efficiency and capability, whilst providing ever-increasing levels of protection.

With a portfolio that includes respiratory and head protection systems, we are renowned for our innovative thinking and our steadfast approach to manufacturing unrivalled products.

For further information, please visit our website www.avon-protection-plc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGZGZMGVKGFZZ
Date   Source Headline
12th Nov 20145:47 pmRNSHolding(s) in Company
6th Nov 20142:21 pmRNSDirector/PDMR Shareholding
8th Oct 20144:06 pmRNSDirector/PDMR Shareholding
3rd Oct 20147:00 amRNSPre close trading update
16th Sep 20146:08 pmRNSHolding(s) in Company
8th Sep 201412:29 pmRNSDirector/PDMR Shareholding
7th Aug 20145:56 pmRNSDirector/PDMR Shareholding
6th Aug 20147:00 amRNSInterim Management Statement
14th Jul 20142:38 pmRNSHolding(s) in Company
9th Jul 20149:30 amRNSDirector/PDMR Shareholding
16th Jun 20145:03 pmRNSHolding(s) in Company
6th Jun 201412:33 pmRNSDirector/PDMR Shareholding
6th Jun 20147:00 amRNSUS $33m order for US DOD
7th May 20144:01 pmRNSDirector/PDMR Shareholding
7th May 20148:47 amRNSHolding(s) in Company
30th Apr 20147:00 amRNSHalf Yearly Report
15th Apr 20141:46 pmRNSHolding(s) in Company
8th Apr 20149:58 amRNSDirector/PDMR Shareholding
1st Apr 20149:13 amRNSHolding(s) in Company
28th Mar 20147:01 amRNSPre close trading update
10th Mar 201412:27 pmRNSHolding(s) in Company
6th Mar 20149:38 amRNSDirector/PDMR Shareholding
6th Mar 20147:00 amRNSUS facility consolidation
17th Feb 20144:58 pmRNSHolding(s) in Company
13th Feb 20145:21 pmRNSHolding(s) in Company
7th Feb 201411:39 amRNSDirector/PDMR Shareholding
6th Feb 20142:10 pmRNSResult of AGM
6th Feb 20147:00 amRNSInterim Management Statement
27th Jan 20148:51 amRNSHolding(s) in Company
14th Jan 20144:30 pmRNSHolding(s) in Company
14th Jan 20144:02 pmRNSDirector/PDMR Shareholding
9th Jan 201411:25 amRNSHolding(s) in Company
7th Jan 20145:14 pmRNSDirector/PDMR Shareholding
30th Dec 20137:00 amRNSHolding(s) in Company
30th Dec 20137:00 amRNSHolding(s) in Company
16th Dec 20139:35 amRNSHolding(s) in Company
11th Dec 201312:44 pmRNSAnnual Financial Report
5th Dec 20134:34 pmRNSDirector/PDMR Shareholding
5th Dec 20133:51 pmRNSDirector/PDMR Shareholding
29th Nov 20133:02 pmRNSDirector/PDMR Shareholding
29th Nov 201311:29 amRNSTotal Voting Rights
25th Nov 201311:15 amRNSIssue of Equity
21st Nov 20132:41 pmRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSFinal Results
6th Nov 20134:50 pmRNSDirector/PDMR Shareholding
30th Oct 20133:17 pmRNSHolding(s) in Company
25th Oct 20137:00 amRNSContract Awards
17th Oct 20139:30 amRNSHolding(s) in Company
8th Oct 20135:49 pmRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSPre close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.